We conclude that IL-1 is a major mediator of the inflammatory cascade that underlies SoJIA and that this cytokine represents a target for therapy in this disease.Juvenile idiopathic arthritis (JIA), which affects an estimated 250,000 children in the United States alone, is an important cause of short- and long-term disability.